Graft versus host disease prophylaxis today

Bone Marrow Transplant. 1991:7 Suppl 2:112-6.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use
  • Antilymphocyte Serum / therapeutic use
  • Bone Marrow Transplantation / adverse effects*
  • Bone Marrow Transplantation / methods
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / therapeutic use
  • Graft Rejection
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / pathology
  • Graft vs Host Disease / prevention & control*
  • Humans
  • Immunosuppression Therapy / methods*
  • Leukemia / surgery
  • Lymphocyte Depletion
  • Mice
  • Neoplasm Recurrence, Local / etiology
  • T-Lymphocytes / immunology
  • Thiotepa / adverse effects
  • Thiotepa / therapeutic use
  • Whole-Body Irradiation / adverse effects

Substances

  • Antibodies, Monoclonal
  • Antilymphocyte Serum
  • Cyclophosphamide
  • Thiotepa